AXSM — Axsome Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual balance sheet for Axsome Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	86.5	201	386	315	323
Net Total Accounts Receivable
Net Total Receivables	—	37.7	94.8	142	224
Total Inventory
Prepaid Expenses
Total Current Assets	86.5	246	504	485	589
Net Property, Plant And Equipment	0.944	1.14	7.62	5.97	21.4
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	87.8	331	588	568	690
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	23.1	96.6	139	230	379
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	72.2	222	397	511	602
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	15.6	110	191	57	88.3
Total Liabilities & Shareholders' Equity	87.8	331	588	568	690
Total Common Shares Outstanding